(相关资料图)
晨光生物披露半年度报告,2023年上半年营业收入约36.69亿元,同比增加13.68%;归母净利润约2.99亿元,同比增加24.23%;基本每股收益0.56元。
2023-08-13
2023-08-04
2023-08-03
2023-08-02
2023-08-01
2023-07-08
2023-07-07
2023-07-06
2023-07-05
2023-07-04
2023-07-03
2023-07-02
2023-07-01
2023-06-30
2023-06-29
2023-06-28
2023-06-27
2023-06-26